A detailed history of Atom Investors LP transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Atom Investors LP holds 47,880 shares of KOD stock, worth $180,986. This represents 0.06% of its overall portfolio holdings.

Number of Shares
47,880
Holding current value
$180,986
% of portfolio
0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$2.6 - $10.9 $124,488 - $521,892
47,880 New
47,880 $476,000
Q2 2024

Aug 14, 2024

BUY
$2.29 - $4.48 $64,211 - $125,619
28,040 Added 16.35%
199,535 $468,000
Q1 2024

May 15, 2024

BUY
$3.01 - $7.45 $200,128 - $495,335
66,488 Added 63.32%
171,495 $902,000
Q4 2023

Feb 14, 2024

BUY
$1.4 - $3.24 $117,644 - $272,263
84,032 Added 400.63%
105,007 $319,000
Q3 2023

Nov 14, 2023

BUY
$1.8 - $7.49 $37,755 - $157,102
20,975 New
20,975 $37,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $197M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.